Stonebrook Private Inc. cut its position in shares of Oracle Co. (NYSE:ORCL – Free Report) by 7.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,059 shares of the enterprise software provider’s stock after selling 245 shares during the quarter. Stonebrook Private Inc.’s holdings in Oracle were worth $432,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. Werlinich Asset Management LLC boosted its stake in shares of Oracle by 3.1% during the 2nd quarter. Werlinich Asset Management LLC now owns 2,325 shares of the enterprise software provider’s stock worth $326,000 after purchasing an additional 70 shares during the period. RFP Financial Group LLC boosted its position in shares of Oracle by 2.7% during the second quarter. RFP Financial Group LLC now owns 2,869 shares of the enterprise software provider’s stock valued at $405,000 after buying an additional 75 shares during the period. ERn Financial LLC boosted its position in shares of Oracle by 0.6% during the second quarter. ERn Financial LLC now owns 12,911 shares of the enterprise software provider’s stock valued at $1,823,000 after buying an additional 80 shares during the period. Key Financial Inc grew its stake in shares of Oracle by 1.2% during the second quarter. Key Financial Inc now owns 6,600 shares of the enterprise software provider’s stock valued at $932,000 after buying an additional 80 shares during the last quarter. Finally, Abich Financial Wealth Management LLC raised its holdings in shares of Oracle by 18.0% in the first quarter. Abich Financial Wealth Management LLC now owns 530 shares of the enterprise software provider’s stock worth $67,000 after buying an additional 81 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Oracle
In other news, insider Edward Screven sold 235,918 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $144.30, for a total value of $34,042,967.40. Following the completion of the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at $379,042,045.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, insider Edward Screven sold 235,918 shares of Oracle stock in a transaction on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total value of $34,042,967.40. Following the completion of the transaction, the insider now directly owns 2,626,764 shares in the company, valued at $379,042,045.20. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of the company’s stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $143.69, for a total value of $161,651,250.00. Following the sale, the chairman now owns 1,145,732,353 shares in the company, valued at approximately $164,630,281,802.57. The disclosure for this sale can be found here. Insiders sold a total of 1,862,500 shares of company stock valued at $266,776,624 in the last three months. 42.80% of the stock is owned by corporate insiders.
Oracle Trading Down 0.6 %
Oracle (NYSE:ORCL – Get Free Report) last posted its earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 EPS for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). Oracle had a net margin of 19.76% and a return on equity of 223.01%. The company had revenue of $14.29 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same period in the previous year, the company earned $1.35 EPS. The company’s quarterly revenue was up 3.3% compared to the same quarter last year. Sell-side analysts forecast that Oracle Co. will post 5.02 earnings per share for the current year.
Oracle Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, July 25th. Investors of record on Thursday, July 11th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Thursday, July 11th. Oracle’s dividend payout ratio (DPR) is 43.13%.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the stock. Morgan Stanley reissued an “equal weight” rating and issued a $125.00 price objective on shares of Oracle in a research report on Tuesday, June 25th. Sanford C. Bernstein increased their price target on Oracle from $159.00 to $171.00 and gave the company an “outperform” rating in a research note on Wednesday, June 12th. StockNews.com lowered shares of Oracle from a “buy” rating to a “hold” rating in a report on Thursday, June 6th. Bank of America increased their price target on shares of Oracle from $144.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, June 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Oracle from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, June 17th. Fourteen equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $145.83.
Read Our Latest Stock Analysis on ORCL
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading
- Five stocks we like better than Oracle
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Conference Calls and Individual Investors
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- What Do S&P 500 Stocks Tell Investors About the Market?
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.